DexCom Total Change in Assets/Liabilities 2010-2024 | DXCM
DexCom annual/quarterly total change in assets/liabilities history and growth rate from 2010 to 2024. Total change in assets/liabilities can be defined as the sum of all line items in the Asset/Liability section of the Cash Flows Statement
- DexCom total change in assets/liabilities for the quarter ending December 31, 2024 was $0.109B, a 3300% increase year-over-year.
- DexCom total change in assets/liabilities for the twelve months ending December 31, 2024 was $0.317B, a 23.53% decline year-over-year.
- DexCom annual total change in assets/liabilities for 2024 was $0.109B, a 3300% increase from 2023.
- DexCom annual total change in assets/liabilities for 2023 was $0.003B, a 88.01% decline from 2022.
- DexCom annual total change in assets/liabilities for 2022 was $0.027B, a 120.23% decline from 2021.
| DexCom Annual Total Change in Assets/Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $109 |
| 2023 | $3 |
| 2022 | $27 |
| 2021 | $-132 |
| 2020 | $-21 |
| 2019 | $6 |
| 2018 | $-41 |
| 2017 | $3 |
| 2016 | $-6 |
| 2015 | $-24 |
| 2014 | $-13 |
| 2013 | $-3 |
| 2012 | $-4 |
| 2011 | $-4 |
| 2010 | $-10 |
| 2009 | $-2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $27.957B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.546B | 80.83 |
| Thermo Fisher Scientific (TMO) | United States | $161.389B | 19.52 |
| Alcon (ALC) | Switzerland | $47.559B | 31.61 |
| Edwards Lifesciences (EW) | United States | $44.842B | 29.34 |
| IDEXX Laboratories (IDXX) | United States | $35.412B | 40.95 |
| IQVIA Holdings (IQV) | United States | $27.056B | 14.97 |
| Mettler-Toledo (MTD) | United States | $22.200B | 25.88 |
| STERIS (STE) | Ireland | $22.012B | 25.17 |
| Waters (WAT) | United States | $20.277B | 28.71 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.073B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.659B | 14.96 |
| Hologic (HOLX) | United States | $13.095B | 14.13 |
| Sysmex ADR (SSMXY) | Japan | $11.834B | 0.00 |
| Penumbra (PEN) | United States | $11.498B | 90.25 |
| Globus Medical (GMED) | United States | $9.948B | 23.03 |
| Masimo (MASI) | United States | $8.815B | 36.99 |
| Teleflex (TFX) | United States | $6.409B | 9.87 |
| Glaukos (GKOS) | United States | $5.356B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.429B | 23.20 |
| TransMedics (TMDX) | United States | $3.126B | 91.51 |
| PROCEPT BioRobotics (PRCT) | United States | $3.115B | 0.00 |
| Veracyte (VCYT) | United States | $2.446B | 44.20 |
| Nihon Kohden (NHNKY) | Japan | $2.137B | 11.68 |
| LivaNova (LIVN) | United Kingdom | $2.047B | 12.43 |
| Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
| Alphatec Holdings (ATEC) | United States | $1.638B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.340B | 6.78 |
| Pulse Biosciences (PLSE) | United States | $1.197B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.116B | 0.00 |
| Artivion (AORT) | United States | $1.024B | 95.96 |
| OPKO Health (OPK) | United States | $0.940B | 0.00 |
| AxoGen (AXGN) | United States | $0.732B | 0.00 |
| IRadimed (IRMD) | United States | $0.683B | 35.80 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 13.94 |
| RxSight (RXST) | United States | $0.619B | 0.00 |
| SiBone (SIBN) | United States | $0.607B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.585B | 9.41 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.551B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.523B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.476B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.443B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.410B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.392B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.337B | 18.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.333B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.326B | 6.92 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.198B | 0.00 |
| Inogen (INGN) | United States | $0.196B | 0.00 |
| 908 Devices (MASS) | United States | $0.196B | 0.00 |
| CVRx (CVRX) | United States | $0.193B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.191B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.163B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.163B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.121B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.102B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.102B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.091B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| InspireMD (NSPR) | Israel | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.073B | 11.12 |
| Hyperfine (HYPR) | United States | $0.057B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.056B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.040B | 0.00 | |
| Spectral AI (MDAI) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.022B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |